Metrics to compare | FDC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFDCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 28.0x | 30.2x | −0.5x | |
PEG Ratio | −1.36 | 1.38 | 0.00 | |
Price / Book | 2.5x | 5.0x | 2.6x | |
Price / LTM Sales | 2.9x | 4.7x | 3.2x | |
Upside (Analyst Target) | - | 6.1% | 48.3% | |
Fair Value Upside | Unlock | −1.9% | 5.6% | Unlock |
FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastrointestinal, ophthalmology, vitamins, minerals, dietary supplements, cardiovascular and anti-diabetic therapies, respiratory care, gynaecology, dermatology, and analgesics in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured ORS powders, ready-to-drink electrolyte beverages, vitamin-enriched supplements, antioxidant blends and protein-fortified drinks; and various active pharmaceutical ingredients. The company sells its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Vitcofol, Ziglim, Ziglim-M,Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Electral, and Enerzal brands. It also exports its products to approximately 50 countries. FDC Limited was founded in 1936 and is based in Mumbai, India.